Department of Medicine 5 – Haematology and Oncology

Daratumomab for the treatment of relapsed multiple myeloma involving the central nervous system: a case report (2019) Brandt A, Seuß H, Mackensen A, Rösler W Conference contribution Monitoring of the immunometabolic profile of reconstituting leukocytes upon autologous peripheral blood stem cell transplantation (2019) Richter S, Jacobs B, Böttcher M, Stoll A, Böttcher-Loschinski R, Mackensen A, Mougiakakos D Conference contribution Successful targeting of BRAF V600E mutation with vemurafenib in a treatment-resistant extragonadal non-seminomatous germ cell tumor (2019) Meintker L, Haller F, Tögel L, Schmidt D, Waibel H, Mackensen A, Meidenbauer N Conference contribution The oncometabolite 5 '-methylthioadenosine (MTA) blocks NK cell functions early after activation (2019) Jacobs B, Schlögl S, Mougiakakos D, Mackensen A, Aigner M, Völkl S Conference contribution Regulation of immunological checkpoints in human mesenchymal stromal cells (2019) Strauch V, Saul D, Mackensen A, Jitschin R, Mougiakakos D Conference contribution AML-derived exosomes promote induction of myeloid-derived suppressor cells in an mTOR-signaling-dependent fashion (2019) Jitschin R, Tohumeken S, Saul D, Bruns H, Braun M, Mackensen A, Mougiakakos D Conference contribution Oxidative stress upon allogeneic hematopoietic stem cell transplantation and its impact on the reconstituting immune system (2019) Karl F, Böttcher-Loschinski R, Stoll A, Rösler W, Mackensen A, Mougiakakos D, Völkl S Conference contribution Human monocytes display different levels of CD137/4-1BB expression linked to certain immunometabolic features (2019) Stoll A, Bruns H, Saul D, Mackensen A, Mougiakakos D Conference contribution „Gesundheit für alle im Stadtteil“ – ein kommunaler Ansatz zur Gesundheitsförderung in sozial benachteiligten Stadtteilen Nürnbergs. (2019) Barth J, Mengel M, Seebaß K, Retzlaff K, Herbert-Maul A, Barthel-Kraus E, Wiemer-Urtube S Book chapter / Article in edited volumes The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease (2019) Srinagesh HK, Özbek U, Kapoor U, Ayuk F, Aziz M, Ben-David K, Choe HK, et al. Journal article